[ Price : $8.95]
Federal Register Notice: FDA seeks information and encourages a public meeting to discuss issues on the clinical development and u...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on establishing the performance characteristics of IVDs for detecting C. di...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on developing drugs to treat hospital-acquired bacterial pneumonia and vent...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on labeling recommendations for blood lancets that the devices be used for only a...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on ANDAs: Impurities in Drug Products.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Antibacterial Drug Products: Use of Noninferiority Trials to Support Approval.[ Price : $8.95]
The Medicines Company reaches agreement with FDA under a Special Protocol Assessment on Phase 3 clinical trials for oritavancin in...[ Price : $8.95]
FDA reviewers question the relevance of clinical trials submitted to support labeling changes for Avodart and Proscar relating the...